A Phase 1 Study to Evaluate the Safety and Immunogenicity of GC4006A in Healthy Adults

NCT07728396 · clinicaltrials.gov ↗

PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

72

Enrollment

INDUSTRY

Sponsor class

Conditions

COVID - 19

Interventions

BIOLOGICAL: GC4006A
DRUG: Normal Saline

Sponsor

GC Biopharma Corp